Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 1032-1036
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.1032
Administration | Agents | Dosage (ng/kg) | Ulcer (mm2) | Inhibition ratio(%) |
im | Saline control | 13.66 ± 4.10 | ||
Excipient control | 13.98 ± 4.00 | |||
Famotidine | 40 000 | 9.18 ± 3.04 | 34.3a | |
BPC 157 | 200 | 9.75 ± 3.62 | 30.2a | |
BPC 157 | 400 | 6.81 ± 3.67 | 51.3b | |
BPC 157 | 800 | 5.60 ± 1.91 | 59.9b | |
ig | Saline control | 14.96 ± 6.21 | ||
Famotidine | 40 000 | 3.20 ± 1.54 | 78.6b | |
BPC 157 | 200 | 9.78 ± 4.28 | 34.6a | |
BPC 157 | 400 | 8.13 ± 2.84 | 45.7b | |
BPC 157 | 800 | 7.80 ± 2.83 | 47.8b |
- Citation: Xue XC, Wu YJ, Gao MT, Li WG, Zhao N, Wang ZL, Bao CJ, Yan Z, Zhang YQ. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol 2004; 10(7): 1032-1036
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/1032.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.1032